Objectives
The first part of the course focuses on the early life cycle and early stages of drug development. The aim is that students understand the logic of the global pharmaceutical market and its future prospects. In addition, the starting points of business related to innovations, drug development and diagnostics are discussed with using real life company examples. The second part of the course focus on the later parts of a drug life cycle. The aim is to familiarize students with Finnish health care system, global market access, health technology assessment and clinical and economical value demonstration of pharmaceuticals.
The first part of the course focuses on the early life cycle and early stages of drug development. The aim is that students understand the logic of the global pharmaceutical market and its future prospects. In addition, the starting points of business related to innovations, drug development and diagnostics are discussed with using real life company examples. The second part of the course focus on the later parts of a drug life cycle. The aim is to familiarize students with Finnish health care system, global market access, health technology assessment and clinical and economical value demonstration of pharmaceuticals.
- Peppi-Teacher: Sampo Koivunen
- Peppi-Teacher: Juha Laine
- Peppi-Teacher: Timo Veromaa